These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20842468)

  • 21. Effect of cardiac resynchronization therapy on global and regional oxygen consumption and myocardial blood flow in patients with non-ischaemic and ischaemic cardiomyopathy.
    Lindner O; Vogt J; Kammeier A; Wielepp P; Holzinger J; Baller D; Lamp B; Hansky B; Körfer R; Horstkotte D; Burchert W
    Eur Heart J; 2005 Jan; 26(1):70-6. PubMed ID: 15615802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric Dilated Cardiomyopathy Patients Do Not Meet Traditional Cardiac Resynchronization Criteria.
    Schiller O; Dham N; Greene EA; Heath DM; Alexander ME; Berul CI
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):885-889. PubMed ID: 25884372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sudden death risk stratification in non-ischemic dilated cardiomyopathy using old and new tools: a clinical challenge.
    Manolis AS
    Expert Rev Cardiovasc Ther; 2017 Apr; 15(4):315-325. PubMed ID: 28292197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ten-year follow-up of cardiac resynchronization therapy patients with non-ischemic dilated cardiomyopathy assessed by radionuclide angiography: a single-center cohort study.
    Valzania C; Massaro G; Spadotto A; Muraglia L; Frisoni J; Martignani C; Ziacchi M; Diemberger I; Fanti S; Boriani G; Biffi M; Galié N
    J Interv Card Electrophysiol; 2022 Sep; 64(3):723-731. PubMed ID: 35175490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
    Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
    Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of extracellular volume fraction by cardiac magnetic resonance imaging and QRS duration for the risk stratification for patients with non-ischemic dilated cardiomyopathy.
    Kodama S; Kato S; Hayakawa K; Azuma M; Kagimoto M; Iguchi K; Fukuoka M; Fukui K; Iwasawa T; Utsunomiya D; Kosuge M; Kimura K; Tamura K
    Heart Vessels; 2020 Oct; 35(10):1439-1445. PubMed ID: 32417957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Right atrial size and deformation in patients with dilated cardiomyopathy undergoing cardiac resynchronization therapy.
    D'Andrea A; Scarafile R; Riegler L; Salerno G; Gravino R; Cocchia R; Castaldo F; Allocca F; Limongelli G; Di Salvo G; Cuomo S; Pacileo G; Caso P; Russo MG; Calabrò R
    Eur J Heart Fail; 2009 Dec; 11(12):1169-77. PubMed ID: 19926601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to beta-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy].
    Shinke T; Takaoka H; Takeuchi M; Hata K; Kawai H; Okubo H; Kijima Y; Murata T; Yokoyama M
    J Cardiol; 2001 Feb; 37(2):119-20. PubMed ID: 11255696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2D/3D Echocardiographic features of patients with reverse remodeling after cardiac resynchronization therapy.
    Cimino S; Maestrini V; Cantisani D; Petronilli V; Filomena D; Gatto MC; Birtolo LI; Piro A; Lavalle C; Agati L
    Echocardiography; 2019 Aug; 36(8):1475-1481. PubMed ID: 31260156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
    McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM
    Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative assessment of cardiac mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy in patients with nonischaemic dilated cardiomyopathy using gated myocardial perfusion SPECT.
    Mukherjee A; Patel CD; Naik N; Sharma G; Roy A
    Nucl Med Commun; 2015 May; 36(5):494-501. PubMed ID: 25695610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac resynchronization therapy induces adaptive metabolic transitions in the metabolomic profile of heart failure.
    Nemutlu E; Zhang S; Xu YZ; Terzic A; Zhong L; Dzeja PD; Cha YM
    J Card Fail; 2015 Jun; 21(6):460-9. PubMed ID: 25911126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial uptake of amino acids and other substrates in relation to myocardial oxygen consumption four hours after cardiac operations.
    Svedjeholm R; Ekroth R; Joachimsson PO; Ronquist G; Svensson S; Tydén H
    J Thorac Cardiovasc Surg; 1991 Apr; 101(4):688-94. PubMed ID: 2008107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors and outcomes of "super-response" to cardiac resynchronization therapy.
    Killu AM; Grupper A; Friedman PA; Powell BD; Asirvatham SJ; Espinosa RE; Luria D; Rozen G; Buber J; Lee YH; Webster T; Brooke KL; Hodge DO; Wiste HJ; Glikson M; Cha YM
    J Card Fail; 2014 Jun; 20(6):379-86. PubMed ID: 24632340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrical remodelling in cardiac resynchronization therapy: decrease in intrinsic QRS duration.
    Mischke K; Knackstedt C; Fache K; Reith S; Rana O; Saygili E; Gemein C; Becker M; Marx N; Schauerte P
    Acta Cardiol; 2011 Apr; 66(2):175-80. PubMed ID: 21591575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome of patients with and without super-response to CRT-D.
    Franke J; Keppler J; Abadei AK; Bajrovic A; Meme L; Zugck C; Raake PW; Zitron E; Katus HA; Frankenstein L
    Clin Res Cardiol; 2016 Apr; 105(4):341-8. PubMed ID: 26497005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement in cardiac energetics by perhexiline in heart failure due to dilated cardiomyopathy.
    Beadle RM; Williams LK; Kuehl M; Bowater S; Abozguia K; Leyva F; Yousef Z; Wagenmakers AJ; Thies F; Horowitz J; Frenneaux MP
    JACC Heart Fail; 2015 Mar; 3(3):202-11. PubMed ID: 25650370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The impact of cardiac resynchronization therapy on left ventricular diastolic function evaluated by speckle tracking imaging in patients with dilated cardiomyopathy].
    Lu J; Dai M; Qian DJ; Zhang CY; Cao LJ; Wang RX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Nov; 41(11):940-4. PubMed ID: 24370222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Selvester QRS score as a predictor of cardiac events in nonischemic dilated cardiomyopathy.
    Hiraiwa H; Okumura T; Sawamura A; Sugiura Y; Kondo T; Watanabe N; Aoki S; Ichii T; Kitagawa K; Kano N; Fukaya K; Furusawa K; Morimoto R; Takeshita K; Bando YK; Murohara T
    J Cardiol; 2018 Mar; 71(3):284-290. PubMed ID: 29066100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.